Your browser doesn't support javascript.
loading
Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer.
Wurlitzer, Marcus; Möckelmann, Nikolaus; Kriegs, Malte; Vens, Maren; Omidi, Maryam; Hoffer, Konstantin; Bargen, Clara von; Möller-Koop, Christina; Witt, Melanie; Droste, Conrad; Oetting, Agnes; Petersen, Hannes; Busch, Chia-Jung; Münscher, Adrian; Schlüter, Hartmut; Clauditz, Till Sebastian; Rieckmann, Thorsten.
Afiliação
  • Wurlitzer M; Mass Spectrometric Proteomics Group, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Möckelmann N; Department of Otorhinolaryngology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Kriegs M; Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Vens M; Department of Medical Biometry and Epidemiology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Omidi M; Institute of Medical Biometry and Statistics, University of Lübeck, 23562 Lübeck, Germany.
  • Hoffer K; Mass Spectrometric Proteomics Group, Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Bargen CV; Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Möller-Koop C; Institute of Pathology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Witt M; Institute of Pathology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Droste C; Institute of Pathology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Oetting A; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Petersen H; Department of Otorhinolaryngology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Busch CJ; Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Münscher A; Department of Otorhinolaryngology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Schlüter H; Department of Otorhinolaryngology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Clauditz TS; Department of Otorhinolaryngology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany.
  • Rieckmann T; Department of Otorhinolaryngology, Marienkrankenhaus, 22087 Hamburg, Germany.
Cancers (Basel) ; 12(6)2020 Jun 11.
Article em En | MEDLINE | ID: mdl-32545200
ABSTRACT
Squamous cell carcinoma of the head and neck (HNSCC) consist of two distinct biological entities. While the numbers of classical, tobacco-induced HNSCC are declining, tumors caused by human papillomavirus (HPV) infection are increasing in many countries. HPV-positive HNSCC mostly arise in the oropharynx and are characterized by an enhanced sensitivity towards radiotherapy and a favorable prognosis. To identify molecular differences between both entities on the protein level, we conducted a mass spectrometric comparison of eight HPV-positive and nine HPV-negative oropharyngeal tumors (OPSCC). Overall, we identified 2051 proteins, of which 31 were found to be differentially expressed. Seventeen of these can be assorted to three functional groups, namely DNA replication, nuclear architecture and cytoskeleton regulation, with the differences in the last group potentially reflecting an enhanced migratory and invasive capacity. Furthermore, a number of identified proteins have been described to directly impact on DNA double-strand break repair or radiation sensitivity (e.g., SLC3A2, cortactin, RBBP4, Numa1), offering explanations for the differential prognosis. The unequal expression of three proteins (SLC3A2, MCM2 and lamin B1) was confirmed by immunohistochemical staining using a tissue microarray containing 205 OPSCC samples. The expression levels of SLC3A2 and lamin B1 were found be of prognostic relevance in patients with HPV-positive and HPV-negative OPSCC, respectively.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article